Mirtazapine
Product Images NDC 45865-361

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 45865-361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuitcals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (361)

Mirtazapine tablets 30 mg packaging label by Medsource Pharmaceuticals. The label indicates the product is a generic for Remeron, with a count of 30 tablets. The tablets are reddish brown, oblong, and film coated. The label includes warnings about dizziness or drowsiness and advises avoiding alcohol.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of the active ingredient Mirtazapine, showing the arrangement of its chemical rings and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.